Emerging Therapies for Chronic Spontaneous Urticaria: Understanding How They Work

Join this expert discussion on the role of IgE in the pathogenesis of CSU and therapies in development.

The goal of this activity is to increase understanding of the pathophysiology of chronic spontaneous urticaria (CSU), the role of immunoglobulin E (IgE), and how novel emerging therapies targeting IgE differ from already approved biologic drugs.

You can find this activity here: https://www.medscape.org/viewarticle/949259

Author: Allen P. Kaplan, MD; Alexander Eggel, PhD - From Medscape Education, April 2021

Since its inception in 2018, COLD-CE has collected data on hundreds of patients with cold urticaria from around the world. In this episode, Dr Mojca Bizjac reflects on her experience of running a UCARE project, offering insight and advice for those hoping to do so in the future.

LINK: https://www.medthority.com/csu-learning-zone/podcast-series/

Read more

5th GA²LEN Global Urticaria Forum (GUF 2020) and 6th Consensus Conference on the Update and Revision of the international EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for Urticaria

Read more

Despite affecting up to 5% of the population, symptomatic dermographism remains understudied. Discover more about how our ability to diagnose and treat this common and debilitating condition is improving from urticaria expert, Dr Tomasz Hawro.

LINK: https://www.medthority.com/csu-learning-zone/podcast-series/

Read more

One of Allergy’s goals is to disseminate your research and expand the readership of your important data. As such, we have created a YouTube channel promoting the articles published in our journal.

Read more

Dr Frank Siebenhaar brings us up to date on the differences between mastocytosis, urticaria and mast cell activation syndrome (MCAS). He also introduces CSUplus, an ongoing UCARE project that aims to shed light on the extracutaneous symptoms of chronic spontaneous urticaria.

LINK: https://www.medthority.com/csu-learning-zone/podcast-series/

Read more

Dr Jorge Sánchez reflects on how it felt to give himself urticaria and explains what his bold experiment has taught us about the role of anti-TPO IgE in this disease.

Link: https://www.medthority.com/csu-learning-zone/podcast-series/

Read more

Angioedema expert and ACARE founding father, Professor Markus Magerl, joins Professor Marcus Maurer to discuss all things angioedema and get the latest on the ever-growing ACARE network. 

Link: https://www.medthority.com/csu-learning-zone/podcast-series/


Read more

Professor Marcus Maurer is joined by Dr Emek Kocatürk Göncü who addresses concerns regarding the impact of COVID-19 infection in patients with chronic urticaria and summarises the results of the recent UCARE project, PREG-CU.

 

Link: https://www.medthority.com/csu-learning-zone/podcast-series/

Read more

For many years, antihistamines have been a cornerstone of chronic urticaria therapy, but is there room for improvement? In this episode, Professor Martin Church reflects on the enormous progress that has been made in the field of urticariology over the course of his career and discusses what is yet to come for patients with this devastating disease.

Link:...

Read more

Professor Marcus Maurer is joined by “UCARE father”, Dr Luis Felipe Ensina, to discuss the frequently underestimated burden of urticaria, which Dr Ensina explains is not limited to the patients themselves, but may indirectly impact numerous friends and family members as well.

Read more

Contact us

GA²LEN coordinating Office
c/o DGAKI
Robert-Koch-Platz 7
10115 Berlin, Germany

UCARE office
Laura Schwenner

info(at)ga2len-ucare.com